ClinicalTrials.gov
public full text
Public Domain
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
This study evaluated the safety and efficacy of an increased frequency of octreotide acetate injections or an increase in dose in partially responsive acromegalic patients with persistently uncontrolled disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The acromegaly patient experience: burden of treatment and quality of life.#262903
- Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly#1031085
- Consensus on acromegaly complications: an update#362531
- Pasireotide LAR and Pegvisomant Study in Acromegaly#837068
- Acromegaly: Patient And Physician Perspectives#872619
Record · ID 908813
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive